Pandemic preparedness and response: Understanding vaccine induced-immunity
The 'Pandemic preparedness and response: Understanding vaccine induced-immunity' program, under Horizon Europe, focuses on strengthening global health security by advancing our understanding of vaccine-induced immunity. This initiative is crucial for developing more effective vaccines and improving pandemic preparedness and response strategies, especially given lessons from the COVID-19 pandemic. It supports collaborative research and innovation actions aimed at enhancing vaccine effectiveness and durability across diverse populations.
Who is Funded and Program Objectives
The 'Understanding Vaccine-Induced Immunity' program targets a broad range of legal entities, including research organizations, higher education establishments, public bodies, and various private enterprises. It aims to foster a comprehensive understanding of vaccine-induced immunity across different populations, addressing critical gaps in knowledge to enhance global health security and pandemic preparedness.
What is Funded: Scope and Focus Areas
This funding program supports research and innovation in public health, focusing on vaccine development and infectious diseases. It covers research and experimental development activities, aiming to generate new knowledge and develop advanced health technologies for pandemic preparedness.
Type and Scope of Funding
The program provides grants as a form of financial support. For this specific topic, the total allocated budget is 20,000,000 EUR, with individual grants ranging from 7,000,000 EUR to 8,000,000 EUR.
Conditions and Requirements for Applicants
Applicants must adhere to various conditions and requirements covering admissibility, eligibility, consortium formation, and operational aspects. These conditions are detailed in various annexes and guiding documents of the Horizon Europe Work Programme and the Funding & Tenders Portal.
Application Procedure
The application process for this program follows a single-stage submission procedure. Applications are submitted via a dedicated online system, and evaluation is based on specific award criteria outlined in the program's general annexes.
Legal Basis
The 'Understanding Vaccine-Induced Immunity' program operates under the overarching legal framework of Horizon Europe, complemented by specific regulations and work programmes that govern its implementation and financial management.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
8,000,000 €
Allocated Budget:
20,000,000 €
Open Until:
Ongoing
Award Channel:
Framework Programme Call
Region:
European Union, United States of America, Multi-Country (countries described in Annex B of the Work Programme General Annexes and Horizon Europe Programme Guide)
Sectors:
Healthcare, Research and Development, Information and Communication Technology, Green Technology, Other
Beneficiaries:
Public health and epidemiology
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Commission
Additional Partners:
European Health Emergency and Response Authority (HERA)
Website: